What Is FDA Adverse Event Management Under MoCRA?

The Modernization of Cosmetics Regulation Act changed adverse-event management from a good customer-service practice into a federal compliance duty. For every cosmetic product marketed in the United States, the Responsible Person must be able to receive health-related complaints, preserve the record, decide whether the event is serious, and submit a qualifying report to the FDA on time. That system must exist before the first complaint arrives — not be improvised after a consumer, distributor, or inspector asks for it.

What is a cosmetic adverse event?

An adverse event is any health-related event associated with the use of a cosmetic product that is adverse. The association does not have to be proven before the report enters the system. A complaint about swelling, a rash, eye irritation, hair loss, infection, a burn, breathing difficulty, or another health effect should be logged and assessed even when causation is uncertain, the consumer used other products, or the initial report contains very little detail. The record should preserve what was reported, when it was received, the product and lot involved, and every follow-up attempt.

When does an adverse event become serious?

MoCRA uses a defined seriousness threshold. An event is serious when it results in death, a life-threatening experience, inpatient hospitalization, persistent or significant disability or incapacity, a congenital anomaly or birth defect, an infection, or significant disfigurement. For cosmetics, significant disfigurement expressly includes serious and persistent rashes, second- or third-degree burns, significant hair loss, and persistent or significant alteration of appearance. An event is also serious when medical or surgical intervention is required to prevent one of those outcomes.

The distinction matters because every event belongs in the record, but serious events trigger the federal reporting clock. A brand should never make that decision from a one-line customer-service ticket alone. It needs a documented assessment, reasonable follow-up questions, and a clear escalation route when the facts are incomplete.

Who is the Responsible Person?

Under MoCRA, the Responsible Person is the manufacturer, packer, or distributor whose name appears on the cosmetic label under the applicable labeling laws. It is not automatically the overseas factory, the US importer, or the company that filed the facility registration. A private-label brand may be the Responsible Person even when another company manufactures the product. That label identity determines who carries the adverse-event duties.

The three operating obligations

1. Recordkeeping: maintain the complete record for every adverse event associated with cosmetic use in the United States. The standard MoCRA period is six years; qualifying small businesses have a three-year statutory minimum. A managed program can retain all cases for six years as one consistent standard.
2. Serious-event reporting: submit the serious adverse event report to the FDA within 15 business days after receipt, with a copy of the product label. Industry reporting uses MedWatch Form 3500A. New medical or other information received during the following year must also be submitted within 15 business days of receipt.
3. Label contact: place a domestic address, domestic telephone number, or electronic contact information on the label so the Responsible Person can receive adverse-event reports, then connect that channel to an actual controlled intake process.

Why foreign brands usually need a US operating partner

The legal duty belongs to the Responsible Person, but the operational problem is often in the United States. Reports may arrive through a US reseller, marketplace, importer, phone number, or label address while the regulatory team is in another time zone. Customer-service staff may not recognize a serious event, distributors may wait for a weekly report, and no one may own the 15-business-day deadline. A US partner can operate the intake channel, ask the right follow-up questions, maintain the case file, assess seriousness, and prepare the FDA submission while the foreign brand remains informed.

A compliant program is required before an event occurs

A brand with no complaint history is not exempt. It still needs a compliant label channel, a written intake and escalation process, a recordkeeping system, and people who know what happens on day one of a report. FDABridge's FDA Adverse Event Management service provides that complete function for cosmetic brands: intake, assessment, MedWatch filing, one-year follow-up, six-year records, and monthly reporting.